Carisma Therapeutics, Inc.CARMNASDAQ
Loading
Year-over-year revenue growth rate
Latest
0.00%
↓ 100% vs avg
Percentile
P31
Within normal range
Streak
1 qtr
Consecutive growthDecelerating
Average
267.20%
Historical baseline
| Period | Value |
|---|---|
| Q3 2025 | 0.00% |
| Q2 2025 | -100.00% |
| Q1 2025 | 2.08% |
| Q4 2024 | 7.92% |
| Q3 2024 | -63.19% |
| Q2 2024 | 170.74% |
| Q1 2024 | -20.80% |
| Q4 2023 | 12.07% |
| Q3 2023 | 7.50% |
| Q2 2023 | 9.77% |
| Q1 2023 | -13.08% |
| Q4 2022 | 44.72% |
| Q3 2022 | -4.62% |
| Q2 2022 | 228.83% |
| Q1 2022 | -95.89% |
| Q4 2021 | 0.00% |
| Q3 2021 | 0.00% |
| Q2 2021 | -100.00% |
| Q1 2021 | 0.00% |
| Q4 2020 | -100.00% |
| Q3 2020 | 0.00% |
| Q2 2020 | 0.00% |
| Q1 2020 | 0.00% |
| Q4 2019 | 0.00% |
| Q3 2019 | 0.00% |
| Q2 2019 | 0.00% |
| Q1 2019 | 0.00% |
| Q4 2018 | 0.00% |
| Q3 2018 | 0.00% |
| Q2 2018 | 0.00% |
| Q1 2018 | 0.00% |
| Q4 2017 | 0.00% |
| Q3 2017 | 0.00% |
| Q2 2017 | -100.00% |
| Q1 2017 | -48.48% |
| Q4 2016 | -97.12% |
| Q3 2016 | 10242.96% |
| Q2 2016 | 20.96% |
| Q1 2016 | -59.47% |
| Q4 2015 | 743.28% |